Using different experimental models and a variety of genetic and pharmacologic approaches, several studies report that the DLL4/NOTCH pathway is a critical negative regulator of tumor angiogenesis, acting to restrain excessive VEGF-induced vascular sprouting and angiogenesis. Here, DLL4 is linked to neoplasm.